These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antimicrobial Resistance Patterns of Gram-negative Bacteria in an Iranian Referral Pediatric Hospital: A Present Danger of New Delhi Metallo-β- lactamase. Mahmoudi S; Pourakbari B; Rostamyan M; Raji H; Sadeghi RH; Mamishi S Infect Disord Drug Targets; 2023; 23(6):e180423215994. PubMed ID: 37106518 [TBL] [Abstract][Full Text] [Related]
23. In vitro activity of cefiderocol against clinically important carbapenem non-susceptible Gram-negative bacteria from Saudi Arabia. Alzayer M; Alghoribi MF; Alalwan B; Alreheli A; Aljohani S; Bosaeed M; Doumith M J Glob Antimicrob Resist; 2023 Mar; 32():176-180. PubMed ID: 36481491 [TBL] [Abstract][Full Text] [Related]
24. Detection of carbapenem-resistant hypervirulent Klebsiella pneumoniae ST11-K64 co-producing NDM-1 and KPC-2 in a tertiary hospital in Wuhan. Huang Y; Li J; Wang Q; Tang K; Cai X; Li C J Hosp Infect; 2023 Jan; 131():70-80. PubMed ID: 36183928 [TBL] [Abstract][Full Text] [Related]
25. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Nordmann P Med Mal Infect; 2014 Feb; 44(2):51-6. PubMed ID: 24360201 [TBL] [Abstract][Full Text] [Related]
26. Prevalence and risk factors of carbapenem-resistant Guo B; Guo Z; Zhang H; Shi C; Qin B; Wang S; Chang Y; Chen J; Chen P; Guo L; Guo W; Han H; Han L; Hu Y; Jin X; Li Y; Liu H; Lou P; Lu Y; Ma P; Shan Y; Sun Y; Zhang W; Zheng X; Shao H Front Microbiol; 2022; 13():894341. PubMed ID: 36187994 [TBL] [Abstract][Full Text] [Related]
27. Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen. Alsharapy SA; Gharout-Sait A; Muggeo A; Guillard T; Cholley P; Brasme L; Bertrand X; Moghram GS; Touati A; De Champs C Microb Drug Resist; 2020 Mar; 26(3):211-217. PubMed ID: 31397629 [No Abstract] [Full Text] [Related]
28. Carbapenem-Resistant Ramadan RA; Bedawy AM; Negm EM; Hassan TH; Ibrahim DA; ElSheikh SM; Amer RM Infect Drug Resist; 2022; 15():3537-3548. PubMed ID: 35833009 [TBL] [Abstract][Full Text] [Related]
29. A silent outbreak due to Duman Y; Ersoy Y; Gursoy NC; Altunisik Toplu S; Otlu B Iran J Basic Med Sci; 2020 Jan; 23(1):46-50. PubMed ID: 32405347 [TBL] [Abstract][Full Text] [Related]
30. The First Egyptian Report Showing the Co-Existence of El-Badawy MF; El-Far SW; Althobaiti SS; Abou-Elazm FI; Shohayeb MM Infect Drug Resist; 2020; 13():1237-1250. PubMed ID: 32425561 [TBL] [Abstract][Full Text] [Related]
31. Clinical carbapenem-resistant Shahid M; Ahmad N; Saeed NK; Shadab M; Joji RM; Al-Mahmeed A; Bindayna KM; Tabbara KS; Dar FK Front Cell Infect Microbiol; 2022; 12():1033305. PubMed ID: 36304935 [TBL] [Abstract][Full Text] [Related]
32. Emergence of KPC-2 and NDM-5-coproducing hypervirulent carbapenem-resistant Zhou Y; Wu X; Wu C; Zhou P; Yang Y; Wang B; Xu Y; Zhao H; Guo Y; Yu J; Yu F mSphere; 2024 Jan; 9(1):e0061223. PubMed ID: 38193656 [TBL] [Abstract][Full Text] [Related]
33. The emergence of carbapenem-resistant Klebsiella pneumoniae isolates producing OXA-48 and NDM in the Southern (Asir) province, Saudi Arabia. Al-Zahrani IA; Alsiri BA Saudi Med J; 2018 Jan; 39(1):23-30. PubMed ID: 29332105 [TBL] [Abstract][Full Text] [Related]
34. Will ceftazidime/avibactam plus aztreonam be effective for NDM and OXA-48-Like producing organisms: Lessons learnt from Pragasam AK; Veeraraghavan B; Shankar BA; Bakthavatchalam YD; Mathuram A; George B; Chacko B; Korula P; Anandan S Indian J Med Microbiol; 2019; 37(1):34-41. PubMed ID: 31424008 [TBL] [Abstract][Full Text] [Related]
35. Clinical and molecular epidemiologic characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonization among neonates in China. Yin D; Zhang L; Wang A; He L; Cao Y; Hu F; Wang C J Hosp Infect; 2018 Sep; 100(1):21-28. PubMed ID: 29763630 [TBL] [Abstract][Full Text] [Related]
36. Dissemination of ST101 blaOXA-48 producing Klebsiella pneumoniae at tertiary care setting. ElMahallawy H; Zafer MM; Al-Agamy M; Amin MA; Mersal MM; Booq RY; Alyamani E; Radwan S J Infect Dev Ctries; 2018 Jun; 12(6):422-428. PubMed ID: 31940293 [TBL] [Abstract][Full Text] [Related]
37. Treatment strategies for OXA-48-like and NDM producing Isler B; Aslan AT; Akova M; Harris P; Paterson DL Expert Rev Anti Infect Ther; 2022 Nov; 20(11):1389-1400. PubMed ID: 36150216 [TBL] [Abstract][Full Text] [Related]
38. A pentaplex real-time PCR assay for rapid identification of major beta-lactamase genes KPC, NDM, CTX, CMY, and OXA-48 directly from bacteria in blood. Hoj TR; McNeely B; Webber K; Welling E; Pitt WG; Ford LC; Robison RA J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878374 [No Abstract] [Full Text] [Related]
39. Emerge of bla Hosseinzadeh Z; Sedigh Ebrahim-Saraie H; Sarvari J; Mardaneh J; Dehghani B; Rokni-Hosseini SMH; Motamedifar M J Chin Med Assoc; 2018 Jun; 81(6):536-540. PubMed ID: 29030025 [TBL] [Abstract][Full Text] [Related]
40. Reliability of carbapenem inactivation method (CIM) and modified carbapenem inactivation method (mCIM) for detection of OXA-48-like and NDM-1. Rizvi M; Sami H; Azam M; Ben Khalid D; Al Jabri Z; Khan F; Sultan A; Singh A; Perween N; Al Quraini M; Al Muharrmi Z; Rizvi SG Indian J Med Microbiol; 2021; 39(4):451-456. PubMed ID: 34330546 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]